James E. Wagner Cultivation: A Mix of Legacy and Innovative Technology, Going Public Soon
Ryan Allway
May 31st, 2018
Exclusive, News, Top News
Canada’s cannabis industry could reach C$22.6 billion over the coming years, according to Deloitte, driven by the legalization of adult-use cannabis later this year. While there are over 100 licensed producers, many analysts believe that there could be a shortfall in production as the country’s domestic market and export opportunities continue to grow, which creates numerous opportunities for investors to profit in the space.
James E. Wagner Cultivation is a unique opportunity in the space that is built upon a long family reputation dating back to the 1920s and 1930s in the tobacco industry. Following the original James Wagner’s legacy, the family-owned business became a licensed producer of medical cannabis under Health Canada’s ACMPR program last year. The company plans to go public in the very near future.
Click here to get a Going Public Alert and see the company’s investor presentation.
Rapidly Expanding Operations, Proprietary Aeroponic Grow System
While James E. Wagner Cultivation, or JWC, started as a small family enterprise and maintains that familial feel, the company has much larger ambitions. Since receiving its initial cultivation license in January 2017, the company has grown consistent, high-quality medical cannabis at its 15,000 sq. ft. facility in Kitchener, Ontario using its patent-pending GrowthStorm™ aeroponic growing technology.
GrowthStorm™ aeroponics at work
The GrowthStorm™ system begins with a cloning process that costs as little as ten cents per cutting with high yields and no contaminants. The plantlets are then inserted into a modular hydroponic growth system based on aeroponic techniques developed at NASA where plant roots hang within an enclosure. Fast and efficient machine-assisted hand-trimming systems along with innovative drying systems round out the process to yield sale-ready products.
In February 2018, the company entered into a lease agreement for a second 345,000 sq. ft. facility in the same city. The company is actively working on a phased expansion of the second facility, which is expected to significantly increase its production rate. Management expects the second facility to be up and running in Q3 of 2018, and to complete the whole facility in Q3 of 2019. JWC believes that, upon completion, the new facility will be the largest aeroponic operation in the world.
JWC 345,000 square foot facility
In addition to its in-house efforts, the company entered into a strategic partnership with Canopy Growth Corp. (TSX: WEED) and its strategic investment arm, Canopy Rivers Corporation. The partnership provides the company with access to high-quality genetics sourced from around the world, industrial scale cannabis oil infrastructure, and a rigorous quality assurance program, as well as online distribution through CraftGrow and Tweed Main Street.
Click here to get a Going Public Alert and see the company’s investor presentation.
Near-term Plans to Go Public
James E. Wagner Cultivation entered into a business combination agreement with AIM1 Ventures Inc. (TSX-V: AIMI) in April 2018, which paves the way for JWC to go public in Canada’s TSX Venture exchange. Under the terms of the deal, JWC will complete an over-subscribed brokered private placement financing for $18.5 million in gross proceeds.
Since the industry’s humble beginning, licensed producers have grown to achieve multi-billion dollar valuations. Canopy Growth Corp. (TSX: WEED) is the largest licensed producer with a market capitalization of more than C$7 billion, but there are at least ten companies in the space with market capitalizations of more than C$1 billion. Canada’s legalization of adult-use cannabis later this year could pave the way to even greater valuations over the coming years.
Investors interested in the space may want to consider companies that are preparing to go public since they aren’t already valued at lofty multiples. In particular, investors may want to consider a company’s operating history, financial performance, and proprietary technologies when evaluating opportunities. Established companies with barriers to entry often represent better opportunities than development-stage companies with higher execution risk.
Looking Ahead
James E. Wagner Cultivation represents a compelling investment opportunity in Canada’s burgeoning cannabis industry. With in-house production ramping up next year and agreements in place with Canopy Growth, the company plans to produce upwards of 30,000 kilograms per year in its combined facilities. These products will be sold into Canada’s rapidly growing market as well as in potential export markets around the world. Interested investors are encouraged to keep an eye out as the company plans to go public in the very near future.
Click here to get a Going Public Alert and see the company’s investor presentation.
Disclaimer
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://cannabisfn.com/legal-disclaimer/
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Watch CFN Media’s exclusive three part interview with Paul Rosen, one of the most active and diversified investors in the emerging cannabis industry. Paul gives his insights on the global cannabis industry and discusses his new endeavors. Become a CFN Media Client Paul Rosen is a noted career entrepreneur and management consultant. Over the last […]
Matthew Nordgren is an ambitious executive, dedicated philanthropist, and accomplished athlete who brings a unique passion to creating strategic alliances. He has breadth and depth of experience in finance, corporate development, and capital sourcing, as well as in building highly motivated teams of skilled professionals. In 2005, Mr. Nordgren received his education at the University […]
Tryp Therapeutics is a pharmaceutical company focused on developing compounds with known activity and/or safety profiles for the treatment of rare diseases and other diseases with high unmet medical needs.
Weekend Unlimited aggregates and scales small to medium cannabis brands in flower, extracts, and edibles.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
